Feng, Xiaodong_ Xie, Hong-Guang - Applying pharmacogenomics in therapeutics-CRC Press (2016)

Pharmacogenomics and Alternative Medicine
269
38. Yin, O.Q., et al. Pharmacogenetics and herb-drug interactions: Experience with Ginkgo
biloba and omeprazole. Pharmacogenetics, 2004;14(12):841–50.
39. Fan, L., et al. Induction of cytochrome P450 2B6 activity by the herbal medicine
baicalin as measured by bupropion hydroxylation. Eur J Clin Pharmacol, 2009;​
65(4):403–9.
40. Fan, L., et al. The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin,
substrate of organic anion-transporting polypeptide 1B1. Clin Pharmacol Ther,
2008;83(3):471–6.
41. Mohammed, A.M., et al. Pharmacodynamic interaction of warfarin with cranberry but
not with garlic in healthy subjects. Br J Pharmacol, 2008;154(8):1691–700.
42. Uno, T., et al. Lack of significant effect of grapefruit juice on the pharmacokinetics of
lansoprazole and its metabolites in subjects with different CYP2C19 genotypes. J Clin
Pharmacol, 2005;45(6):690–4.
43. Gervasini, G., et al. The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 polymorphisms
and gender on the urinary excretion of the metabolites of the H-receptor
antihistamine ebastine: A pilot study. Br J Clin Pharmacol, 2006;62(2):177–86.
44. Li, X., et al. The rs1142345 in TPMT affects the therapeutic effect of traditional
hypoglycemic herbs in prediabetes. Evid Based Complement Alternat Med, 2013;​
2013:327629.
45. Rondanelli, M., et al. Beneficial effects of artichoke leaf extract supplementation on
increasing HDL-cholesterol in subjects with primary mild hypercholesterolaemia:
A double-blind, randomized, placebo-controlled trial. Int J Food Sci Nutr, 2013;​
64(1):7–15.
46. Li, H., et al. Flavonoids from artichoke (Cynara scolymus L.) up-regulate endothelialtype
nitric-oxide synthase gene expression in human endothelial cells. J Pharmacol
Exp Ther, 2004;310(3):926–32.
47. Xia, N., et al. Artichoke, cynarin and cyanidin downregulate the expression of inducible
nitric oxide synthase in human coronary smooth muscle cells. Molecules, 2014;​
19(3):3654–68.
48. Jacociunas, L.V., et al. Protective activity of Cynara scolymus L. leaf extract against
chemically induced complex genomic alterations in CHO cells. Phytomedicine, 2013;​
20(12):1131–34.
49. Shiner, M., B. Fuhrman, and M. Aviram. Macrophage paraoxonase 2 (PON2) expression
is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR gamma and
AP-1 pathway activation. Atherosclerosis, 2007;195(2):313–21.
50. Rosenblat, M., N. Volkova, and M. Aviram. Pomegranate juice (PJ) consumption
antioxidative properties on mouse macrophages, but not PJ beneficial effects on macrophage
cholesterol and triglyceride metabolism, are mediated via PJ-induced stimulation
of macrophage PON2. Atherosclerosis, 2010;212(1):86–92.
51. Malik, A., et al. Pomegranate fruit juice for chemoprevention and chemotherapy of
prostate cancer. Proc Natl Acad Sci U S A, 2005;102(41):14813–18.
52. Faria, A., et al. Pomegranate juice effects on cytochrome P450S expression: In vivo
studies. J Med Food, 2007;10(4):643–9.
53. Hidaka, M., et al. Effects of pomegranate juice on human cytochrome p450 3A
(CYP3A) and carbamazepine pharmacokinetics in rats. Drug Metab Dispos, 2005;​
33(5):644–8.
54. Voruganti, S., et al. Effect of pomegranate juice on intestinal transport and pharmacokinetics
of nitrendipine in rats. Phytother Res, 2012;26(8):1240–45.
55. Shen, Y., et al. Verification of the antidiabetic effects of cinnamon (Cinnamomum zeylanicum)
using insulin-uncontrolled type 1 diabetic rats and cultured adipocytes. Biosci
Biotechnol Biochem, 2010;74(12):2418–25.